Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation.
Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Soga Y, Hirano K, Yamaguchi T, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI Investigators. Yamauchi Y, et al. Among authors: sugano t. J Vasc Interv Radiol. 2022 Jul;33(7):826-833.e1. doi: 10.1016/j.jvir.2022.03.602. Epub 2022 Apr 7. J Vasc Interv Radiol. 2022. PMID: 35398480 Free article.
One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. Yamauchi Y, et al. Among authors: sugano t. Circ Cardiovasc Interv. 2019 Jan;12(1):e007441. doi: 10.1161/CIRCINTERVENTIONS.118.007441. Circ Cardiovasc Interv. 2019. PMID: 30616363 No abstract available.
Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Soga Y, Tsubakimoto Y, Yokoi H, Miyamoto A, Nakamura M. Yamauchi Y, et al. Among authors: sugano t. Circ Cardiovasc Interv. 2020 Aug;13(8):e009168. doi: 10.1161/CIRCINTERVENTIONS.120.009168. Epub 2020 Jul 29. Circ Cardiovasc Interv. 2020. PMID: 32755323 No abstract available.
Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan.
Mori S, Hirano K, Yamauchi Y, Hayashi E, Doijiri T, Takamura T, Maeda A, Okuda J, Mizuno K, Onishi Y, Iwaki T, Tsukahara K, Shinozaki N, Araki H, Kongoji K, Sugano T, Miyamoto A, Michishita I. Mori S, et al. Among authors: sugano t. Heart Vessels. 2017 Sep;32(9):1093-1098. doi: 10.1007/s00380-017-0982-7. Epub 2017 Apr 27. Heart Vessels. 2017. PMID: 28451834
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation.
Nakamura M, Iijima R, Ako J, Shinke T, Okada H, Ito Y, Ando K, Anzai H, Tanaka H, Ueda Y, Takiuchi S, Nishida Y, Ohira H, Kawaguchi K, Kadotani M, Niinuma H, Omiya K, Morita T, Zen K, Yasaka Y, Inoue K, Ishiwata S, Ochiai M, Hamasaki T, Yokoi H; NIPPON Investigators. Nakamura M, et al. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1189-1198. doi: 10.1016/j.jcin.2017.04.019. JACC Cardiovasc Interv. 2017. PMID: 28641838 Free article. Clinical Trial.
412 results